Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00070486 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: celecoxib
DRUG: gemcitabine hydrochloride
DRUG: zileuton

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]